当前位置:
首页>产品中心>单抗/多抗>Vibecotamab ELISA Kit|维贝考他单抗ELISA检测试剂盒(靶标:维贝考他单抗酶联免疫检测试剂盒)
Vibecotamab ELISA Kit|维贝考他单抗ELISA检测试剂盒(靶标:维贝考他单抗酶联免疫检测试剂盒)
- 货号:RB9TDB714028
- 价格:面议
- 点击:448
产品介绍
产品参数
| 应用 | ELISA |
|---|
| 检测方法 | Colorimetric |
|---|
| 灵敏度 | 0.156 μg/ml |
|---|
| 检测范围 | 0.31-5 μg/mL |
|---|
| 回收率 | 80-120% |
|---|
| 样本类型 | Plasma, Serum |
|---|
| 检测类型 | Quantitative |
|---|
| 稳定性和储存 | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
|---|
| 运输条件 | 2-8 ℃ |
|---|
| 登录号 | P26951 & P07766 |
|---|
| 背景信息 | Vibecotamab (XmAb®14045) is a tumor-targeted antibody that contains both a CD123 binding domain and a cytotoxic T-cell binding domain (CD3) in a Phase 1 clinical trial for the treatment of acute myeloid leukemia (AML) and other CD123-expressing hematologic malignancies. An XmAb Bispecific Fc domain serves as the scaffold for these two antigen binding domains and confers long circulating half-life, stability and ease of manufacture on vibecotamab. CD123 is highly expressed on AML cells and leukemic stem cells, and it is associated with poorer prognosis in AML patients. Engagement of CD3 by vibecotamab activates T cells for highly potent and targeted killing of CD123-expressing tumor cells. |
|---|
| 别名 | XmAb14045, 2138442-13-2 |
|---|
| 备注 | For Research Use Only. |
|---|
【仅供科学研究使用】
相关产品: